The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy

Journal of Obstetrics and Gynaecology

Volumn 33, Issue 1, 2013, Pages 1-8

  Hutson, J R ^a,b   Matlow, J N ^a,b   Moretti, M E ^a   Koren, G ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

6 mercaptopurine; Azathioprine; Meta analysis; Pregnancy

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; TUMOR NECROSIS FACTOR INHIBITOR;

COHORT ANALYSIS; CONGENITAL MALFORMATION; CORTICOSTEROID THERAPY; DRUG SAFETY; ENTERITIS; FETUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW BIRTH WEIGHT; META ANALYSIS; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW;

6-MERCAPTOPURINE; ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; ANIMALS; AZATHIOPRINE; BIRTH WEIGHT; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH;

EID: 84871496472     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2012.716106     Document Type: Review

References (41)

1. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. 1990. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 99:443-446.
2. Angelberger S, Reinisch W, Messerschmidt A, Miehsler W, Novacek G, Vogelsang H et al. 2011. Long-term follow-up of babies exposed to aza-thioprine in utero and via breastfeeding. Journal of Crohn's and Colitis 5:95-100.
3. Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. 2006. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 55: 47-53.
4. Baiocco PJ, Korelitz BI. 1984. The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. Journal of Clinical Gastroenterology 6:211-216.
5. Baird DD, Narendranathan M, Sandler RS. 1990. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 99:987-994.
6. Bortoli A, Saibeni S, Tatarella M, Prada A, Beretta L et al. 2007. Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. Journal of Gastroenterology and Hepatology 22: 542-549.
7. Campbell S, Ghosh S. 2000. Safety of azathioprine use in pregnancy. Gut 46: A13.
8. Cleary BJ, Kallen B. 2009. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Research. Part A, Clinical and Molecular Teratology 85:647-654.
9. Coelho J, Beaugerie L, Colombel JF, Hebuterne X, Lerebours E, Lemann M et al. 2011. Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 60:198-203.
10. Cooper GS, Stroehla BC. 2003. The epidemiology of autoimmune diseases. Autoimmunity Reviews 2:119-125.
11. Cornish J, Tan E, Teare J, Teoh TG, Rai R, Clark SK et al. 2007. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56:830-837.
12. Davis AR, Miller L, Tamimi H, Gown A. 1999. Methotrexate compared with mercaptopurine for early induced abortion. Obstetrics and Gynecology 93:904-909.
13. Dejaco C, Angelberger S, Waldhoer T, Meihsler W, Wenzl H, Haas T et al. 2005. Pregnancy and birth outcome under thiopurine therapy for inflam-matory bowel disease (IBD). Gastroenterology 128: A12.
14. Dominitz JA, Young JC, Boyko EJ. 2002. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. American Journal of Gastroenterology 97:641-648.
15. Fedorkow DM, Persaud D, Nimrod CA. 1989. Inflammatory bowel disease: a controlled study of late pregnancy outcome. American Journal of Obstetrics and Gynecology 160:998-1001.
16. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. 2003. The safety of 6-mercaptopurine for childbearing patients with inflam-matory bowel disease: a retrospective cohort study. Gastroenterology 124: 9-17.
17. Goldstein LH, Dolinsky G, Greenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrin O et al. 2007. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Research. Part A, Clinical and Molecular Teratology 79:696-701.
18. Hanauer SB. 1999. Updating the approach to Crohn's disease. Hospital Practice (Minneapolis) 34: 77-78, 81-83, 87-93.
19. Jain V, Gordon C. 2011. Managing pregnancy in inflammatory rheumato-logical diseases. Arthritis Research and Terapy 13:206.
20. Khan ZH, Mayberry JF, Spiers N, Wicks AC. 2000. Retrospective case series analysis of patients with inflammatory bowel disease on azathioprine. A district general hospital experience. Digestion 62:249-254.
21. Kwan LY, Mahadevan U. 2010. Inflammatory bowel disease and pregnancy: An update. Expert Review of Clinical Immunology 6: 643-657.
22. Landy HJ, Isada NB, McGinnis J, Ratner R, Grossman JH 3rd.1988. The Effect of chronic steroid therapy on glucose tolerance in pregnancy. American Journal of Obstetrics and Gynecology 159:612-615.
23. Langagergaard V, Pedersen L, Gislum M, Norgard B, Sorensen HT. 2007. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study. Alimentary Pharmacology and Terapeutics 25:73-81.
24. Levy N, Roisman I, Teodor I. 1981. Ulcerative colitis in pregnancy in Israel. Diseases of the Colon and Rectum 24: 351-354.
25. Ludvigsson JF, Ludvigsson J. 2002. Inflammatory bowel disease in mother or father and neonatal outcome. Acta Paediatrica 91:145-151.
26. Mountifield RE, Prosser R, Bampton P, Muller K, Andrews JM. 2010. Pregnancy and IBD treatment: This challenging interplay from a patients'perspective. Journal of Crohn's and Colitis 4:176-182.
27. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R et al. 2011. Guidelines for the management of inflammatory bowel disease in adults. Gut 60:571-607.
28. Nørgård B, Pedersen L, Fonager K, Rasmussen SN, Sørensen HT. 2003. Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Alimentary Pharmacology and Terapeutics 17:827-834.
29. Norgard B, Pedersen L, Christensen LA, Sorensen HT. 2007. Therapeutic drug use in women with Crohn's disease and birth outcomes: A Danish nationwide cohort study. American Journal of Gastroenterology 102:1406-1413.
30. Osting VC, Carter JD. 2010. A safety assessment of tumor necrosis factor antagonists during pregnancy. Expert Opinion on Drug Safety 9: 421-429.
31. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L et al. 2000. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385-392.
32. Peyrin-Biroulet L, Oussalah A, Roblin X, Sparrow MP. 2011. The use of aza-thioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts. Alimentary Pharmacology and Terapeutics 33:707-713.
33. Platzek T, Bochert G. 1996. Dose-response relationship of teratogenic-ity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice. Teratogenesis, Carcinogenesis, and Mutagenesis 16: 169-181.
34. Polifa JE, Friedman JM. 2002. Teratogen update: azathioprine and 6-mercaptopurine. Teratology 65:240-261.
35. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 1989. 6-Mercaptopurine in the management of inflammatory bowel disease: short-and long-term toxicity. Annals of Internal Medicine 111:641-649.
36. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. 2008. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reproductive Toxicology 25:271-275.
37. Schatz M, Dombrowski M P, Wise R, Momirova V, Landon M, Mabie W et al. 2004. The relationship of asthma medication use to perinatal outcomes. Journal of Allergy and Clinical Immunology 113: 1040-1045.
38. Shim L, Eslick GD, Simring AA, Murray H, Weltman MD. 2011. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). Journal of Crohn's and Colitis 5: 234-238.
39. Tennenbaum R, Marteau P, Elefan TE, Rambaud JC, Modigliani R, Gendre JP et al. 1999. [Pregnancy outcome in inflammatory bowel diseases]. Gastroenterologie Clinique et Biologique 23:464-469.
40. Timmer A, McDonald JW, Macdonald JK. 2007. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews (1):CD000478.
41. Woolfson K, Cohen Z, McLeod RS. 1990. Crohn's disease and pregnancy. Diseases of the Colon and Rectum 33: 869-873.